Therapy for Cancer at Stomach and Esophagous junctio
Not Applicable
- Conditions
- Health Condition 1: null- Patients with resectable Carcinoma Gastroesophageal junction without clinical metastasis
- Registration Number
- CTRI/2018/05/013757
- Lead Sponsor
- Dr Shivendra Singh
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All patients with resectable and hitologically proven adenocarcinoma of Gastroesophageal junction(type I,II,III) who are fit for surgery(ECOG performance status 0,1,2); No Distant metastasis on PET scan and Staging Laparoscopy
Exclusion Criteria
Distant metastasis on Staging Laparoscopy or on PET scan; refusal for informed consent for procedure; locally unresectable tumors; tumors falling in stage cT1N0 on Endoscopic ultrasound examination
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparison of median survival rates in patient treated with NACT followed by surgery with NACTRT followed by surgeryTimepoint: 30 days from surgery ; 3 month; 6 month; 1 year; 3 years ; 5 years
- Secondary Outcome Measures
Name Time Method Pathological response; Progression free survival; number of R0 resections; treatment toxicity; quality of lifeTimepoint: 30 days from surgery ; 3 month; 6 month; 1 year; 3 years ; 5 years